SMTL ID : 4d1x.1

CDK2 in complex with Luciferin

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

monomer

Ligands

1 x ESJ: (4S)-2-(6-hydroxy-1,3-benzothiazol-2-yl)-4,5-dihydro-1,3-thiazole-4-carboxylic acid(Non-covalent)

ESJ.1: 16 residues within 4Å: Chain A: I.10, G.13, T.14, V.18, A.31, K.33, V.64, F.80, E.81, F.82, L.83, K.129, Q.131, N.132, L.134, D.145 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:A.31, A:V.64, A:F.80, A:L.134 Hydrogen bonds: A:T.14, A:T.14, A:K.33, A:E.81, A:L.83, A:D.145 Salt bridges: A:K.33, A:K.129

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Rothweiler, U. et al., Luciferin and Derivatives as a Dyrk Selective Scaffold for the Design of Protein Kinase Inhibitors. Eur.J.Med.Chem. (2015)

Release Date

2015-03-18

Peptides

CYCLIN-DEPENDENT KINASE 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

CYCLIN-DEPENDENT KINASE 2

Related Entries With Identical Sequence